Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Related Articles by Review for PubMed (Select 20453831)

1.

Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.

Bellodi C, Kopmar N, Ruggero D.

EMBO J. 2010 Jun 2;29(11):1865-76. doi: 10.1038/emboj.2010.83. Epub 2010 May 7.

2.

Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway.

Chakraborty A, Uechi T, Kenmochi N.

Wiley Interdiscip Rev RNA. 2011 Jul-Aug;2(4):507-22. doi: 10.1002/wrna.73. Epub 2011 Jan 20. Review.

PMID:
21957040
3.

p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics.

Halaby MJ, Yang DQ.

Gene. 2007 Jun 15;395(1-2):1-7. Epub 2007 Feb 16. Review.

PMID:
17395405
4.

Dyskeratosis congenita: a disorder of defective telomere maintenance?

Walne AJ, Marrone A, Dokal I.

Int J Hematol. 2005 Oct;82(3):184-9. Review.

PMID:
16207588
5.

p53 and little brother p53/47: linking IRES activities with protein functions.

Grover R, Candeias MM, Fåhraeus R, Das S.

Oncogene. 2009 Jul 30;28(30):2766-72. doi: 10.1038/onc.2009.138. Epub 2009 Jun 1. Review.

PMID:
19483723
6.

Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.

Marrone A, Dokal I.

Expert Rev Mol Med. 2004 Dec 20;6(26):1-23. Review.

PMID:
15613268
7.

Dyskeratosis congenita: a genetic disorder of many faces.

Kirwan M, Dokal I.

Clin Genet. 2008 Feb;73(2):103-12. Epub 2007 Nov 14. Review.

PMID:
18005359
8.

Ribosomopathies: human disorders of ribosome dysfunction.

Narla A, Ebert BL.

Blood. 2010 Apr 22;115(16):3196-205. doi: 10.1182/blood-2009-10-178129. Epub 2010 Mar 1. Review.

9.

Growth control and ribosomopathies.

Teng T, Thomas G, Mercer CA.

Curr Opin Genet Dev. 2013 Feb;23(1):63-71. doi: 10.1016/j.gde.2013.02.001. Epub 2013 Mar 13. Review.

PMID:
23490481
10.

Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site.

Jang SK, Pestova TV, Hellen CU, Witherell GW, Wimmer E.

Enzyme. 1990;44(1-4):292-309. Review.

PMID:
1966843
11.

Major heat shock protein Hsp72 controls oncogene-induced senescence.

Sherman M.

Ann N Y Acad Sci. 2010 Jun;1197:152-7. doi: 10.1111/j.1749-6632.2010.05196.x. Review.

PMID:
20536844
12.

Dyskeratosis congenita and telomerase.

Bessler M, Wilson DB, Mason PJ.

Curr Opin Pediatr. 2004 Feb;16(1):23-8. Review.

PMID:
14758110
13.

Does the ribosome translate cancer?

Ruggero D, Pandolfi PP.

Nat Rev Cancer. 2003 Mar;3(3):179-92. Review.

PMID:
12612653
14.

Activation of p53 by oncogenes.

Lowe SW.

Endocr Relat Cancer. 1999 Mar;6(1):45-8. Review.

15.

Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.

Dasgupta A, Das S, Izumi R, Venkatesan A, Barat B.

FEMS Microbiol Lett. 2004 May 15;234(2):189-99. Review.

16.

Distinct roles of MDMX in the regulation of p53 response to ribosomal stress.

Gilkes DM, Chen J.

Cell Cycle. 2007 Jan 15;6(2):151-5. Epub 2007 Jan 13. Review.

17.
18.

Nucleolus, ribosomes, and cancer.

Montanaro L, Treré D, Derenzini M.

Am J Pathol. 2008 Aug;173(2):301-10. doi: 10.2353/ajpath.2008.070752. Epub 2008 Jun 26. Review.

19.

IRES mediated translational regulation of p53 isoforms.

Sharathchandra A, Katoch A, Das S.

Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):131-9. doi: 10.1002/wrna.1202. Epub 2013 Nov 7. Review.

PMID:
24343861
20.

The role of p53 in ribosomopathies.

Fumagalli S, Thomas G.

Semin Hematol. 2011 Apr;48(2):97-105. doi: 10.1053/j.seminhematol.2011.02.004. Review.

PMID:
21435506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk